BRIEF published on 12/01/2025 at 15:58, 9 months 11 days ago Vanguard Group Discloses Position in American Axle & Manufacturing The Vanguard Group Takeover Code Securities Disclosure Investment Position American Axle
BRIEF published on 12/01/2025 at 15:58, 9 months 11 days ago Vanguard Group dévoile sa position dans American Axle & Manufacturing Code De Prise De Contrôle Le Groupe Vanguard Information Sur Les Valeurs Mobilières Position D'investissement Essieu Américain
BRIEF published on 12/01/2025 at 15:57, 9 months 11 days ago Vanguard Group Discloses Stake in JTC plc Securities Takeover Code Stake Vanguard JTC Plc
BRIEF published on 12/01/2025 at 15:57, 9 months 11 days ago Le groupe Vanguard révèle sa participation dans JTC plc Titres Code De Prise De Contrôle Avant-garde Miser JTC Plc
BRIEF published on 12/01/2025 at 15:56, 9 months 11 days ago The Vanguard Group Discloses Position in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Vanguard Group Shareholding Avadel Pharmaceuticals
BRIEF published on 12/01/2025 at 15:56, 9 months 11 days ago Le groupe Vanguard révèle sa participation dans Avadel Pharmaceuticals Actionnariat Groupe Vanguard Formulaire 8.3 Avadel Pharmaceuticals Panel Irlandais Des OPA
BRIEF published on 12/01/2025 at 15:55, 9 months 11 days ago The Vanguard Group Discloses Position in Greencore Group The Vanguard Group Takeover Code Public Disclosure Securities Position Greencore Group
BRIEF published on 12/01/2025 at 15:55, 9 months 11 days ago Le groupe Vanguard révèle sa participation dans le groupe Greencore. Code De Prise De Contrôle Le Groupe Vanguard Divulgation Publique Groupe Greencore Position Sur Titres
BRIEF published on 12/01/2025 at 15:53, 9 months 11 days ago The Vanguard Group Discloses Position in Spire Healthcare Group plc Form 8.3 Takeover Code Vanguard Group Spire Healthcare Shareholding Disclosure
BRIEF published on 12/01/2025 at 15:53, 9 months 11 days ago Le groupe Vanguard révèle sa participation dans Spire Healthcare Group plc Spire Healthcare Groupe Vanguard Code De Prise De Contrôle Formulaire 8.3 Déclaration Relative À L'actionnariat
Published on 09/12/2026 at 02:35, 21 hours 26 minutes ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 1 hour ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 2 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 7 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 6 hours 11 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 16 hours 31 minutes ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 1 hour ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 1 hour ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 4 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 1 day 17 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 1 day 17 hours ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 4 hours ago Availability of the 2026 Interim Financial Report
